Indegene Acquires US-based Encima Group to Strengthen Omnichannel Analytics Capabilities
ISELIN, New Jersey, December 1, 2016 /PRNewswire/ --
Indegene (http://www.indegene.com), a global healthcare solutions provider, today announced the acquisition of The Encima Group - a pioneer in life science omnichannel marketing automation and analytics and partner to some of the world's largest pharmaceutical organizations. The Delaware Corporation was featured for the 4th consecutive year in the prestigious Inc. 5000 list of fastest-growing private companies in the United States.
(Logo: http://photos.prnewswire.com/prnh/20141208/720248 )
The life science industry is undergoing a technology-enabled transformation of its sales and marketing models to become more cost-effective, efficient, compliant, and customer-centric. Omnichannel marketing coupled with hybrid sales models enable data-driven, targeted, and personalized customer engagement, resulting in better business outcomes and superior customer experience.
"Indegene brings global scale and deep expertise in multichannel marketing, technology, and content. These capabilities combined with Encima's capabilities in MCM analytics, marketing automation, and digital strategy will help customers successfully transform and modernize their commercial operations," said Manish Gupta, CEO, Indegene. "We're delighted to partner with Encima and welcome the exceptionally talented Encima team to the Indegene family. This transaction creates a category-leading omnichannel marketing solution for sales and marketing transformation," added Dr. Rajesh Nair, President, Indegene.
Encima has 60 employees in the United States and counts some of the top 10 pharmaceutical companies as its clients. "We're delighted to partner with Indegene. Through our combined strengths we will now be able to go after a mega opportunity. Indegene brings global scale and deep expertise in commercial analytics and operations with medical expertise as a key differentiator. Our combined capabilities will help customers successfully transform to meet the needs of the rapidly evolving healthcare environment," said David Clunes, President and CEO, Encima Group.
"The complementary analytics and digital solutions of both companies will enable clients to consume and institutionalize actionable multichannel and digital analytics. This combination has the potential to create strong market leadership quickly. The Encima team is excited about joining the Indegene family," added Shouvanik Chatterjee, COO, Encima Group.
Indegene enables global healthcare organizations to address complex challenges by seamlessly integrating analytics, technology, operations, and medical expertise and drive better health and business outcomes. Indegene's IP-based solutions help clients drive revenues and productivity by making transformational leaps in digitalization of customer engagement, health reform, healthcare cost reduction, and health outcomes improvement.
About Encima Group:
Encima provides omnichannel marketing execution and analytics solutions to Fortune 1000 clients in the pharmaceutical and life sciences industries. These solutions help clients establish enterprise capabilities in marketing and analytics through operational excellence, innovative digital data collection strategies, data visualization, and actionable analytics insights rooted in deep domain expertise.
Encima has US offices in Princeton, NJ, Newark, DE, and Chicago, IL, among other locations.
For more information, visit http://www.encimagroup.com
Media contact: Kiran John email@example.com